✦ LIBER ✦

The Impact of Neoadjuvant Chemotherapy on Patients with Locally Advanced Breast Cancer in a Nigerian Semiurban Teaching Hospital: A Single-center Descriptive Study

✍ Scribed by Olukayode Adeolu Arowolo; Andrew Akinbolaji Akinkuolie; Oladejo Olukayode Lawal; Olusegun Isaac Alatise; Abdulkadir Ayo Salako; Adewale Oluseye Adisa

Publisher: Springer
Year: 2010
Tongue: English
Weight: 187 KB
Volume: 34
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s00268-010-0617-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Invited Commentary: The Impact of Neoadj

Invited Commentary: The Impact of Neoadjuvant Chemotherapy on Patients with Locally Advanced Breast Cancer in a Nigerian Semiurban Teaching Hospital: A Single-Center Descriptive Study

✍ Ines Buccimazza 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 109 KB

Docetaxel plus epidoxorubicin as neoadju

Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast : A single-center, Phase II study

✍ Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##

Longitudinal study of the assessment by

Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

✍ Uma Sharma; Karikanni Kalathil A. Danishad; Vurthaluru Seenu; Naranamangalam R. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views